SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $2,322,922,487 |
| Positions | 68 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ERASCA INC | ERAS | COM | $222,588,000 | 12,150,000 |
| ABIVAX SA | ABVX | SPONSORED ADS | $136,458,240 | 1,024,000 |
| REVOLUTION MEDICINES INC | RVMD | COM | $131,096,000 | 700,000 |
| IDEAYA BIOSCIENCES INC | IDYA | COM | $111,810,000 | 3,000,000 |
| BIONTECH SE | BNTX | SPONSORED ADS | $94,445,750 | 1,015,000 |
| VERA THERAPEUTICS INC | VERA | CL A | $94,402,000 | 2,200,000 |
| TANGO THERAPEUTICS INC | TNGX | COM | $89,091,000 | 2,850,000 |
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $87,045,400 | 260,000 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | COM NEW | $78,141,000 | 2,100,000 |
| DIANTHUS THERAPEUTICS INC | DNTH | COM | $77,984,000 | 800,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.